It Is Not About Having More Machines,
but Having More Precise Choices.
From seeing the disease clearly to choosing the right technology for treatment.
From precision PET/MR and multimodal image fusion to multi-platform radiotherapy with CyberKnife, TomoTherapy, TrueBeam, Halcyon and Ethos, the goal is to build an integrated precision oncology technology system that can be selected and combined according to lesion location, number, size, motion and treatment objectives.
When lesion characteristics and treatment goals differ, imaging, planning methods, radiotherapy platforms and motion-management strategies may also need to change.
SEE
PLAN
TREAT
ADAPT
An Integrated System, Not a Single Machine.
This opening section provides a quick technology map. The following sections will focus on clinically differentiated technologies, real-world application experience and translation into practice.
Tumors Change. The Body Changes.
Treatment Technology Can Adapt Too.
Precision radiotherapy is moving beyond a “plan once, deliver repeatedly” model toward faster image verification, online adaptation and dynamic tracking. The focus here is not how many machines are available, but how these technologies can actually change the treatment process.
HyperSight
In September 2025, the hospital completed its Halcyon v4.0 upgrade and implemented HyperSight clinically in China for the first time. Faster, higher-quality treatment imaging helps doctors verify the patient’s anatomy and target position more clearly before each treatment.
Ethos Adaptive Radiotherapy
Organ position, filling status and tumor anatomy can vary from day to day. Online adaptive technology can reassess and optimize the treatment plan using the imaging acquired that day.
Image
Anatomy
Optimize
Treatment
HyperArc
The hospital has accumulated substantial experience in precision radiotherapy for brain tumors and multiple brain metastases. For complex intracranial multi-target cases, HyperArc uses a single isocenter, non-coplanar geometry and highly automated stereotactic radiotherapy workflows to improve treatment efficiency.
Clinical Treatment Volume
For lung, liver and other lesions that move with breathing, different imaging and motion-management techniques can be combined for positioning and treatment.
Precision Treatment
Does Not Always Begin Outside the Body.
For selected solid tumors, treatment may use vascular intervention, local drug delivery, ablation or radionuclide therapy to target the tumor or its blood supply more directly. The goal is not to “use every technique,” but to determine which local treatment is appropriate for the current clinical objective.
Interventional Chemotherapy
A vascular catheter is advanced into the tumor-related blood supply to deliver medication locally according to the disease status and treatment objective. Suitability depends on factors such as cancer type, vascular anatomy, tumor burden and the patient’s overall condition.
Local Drug DeliveryTumor Vascular Intervention
Based on the tumor’s blood-supply characteristics, vascular intervention may be used for embolization or other local treatments, with the goal of targeting tumor perfusion and local disease.
Targeting Tumor Blood SupplyTumor Ablation
For selected localized or oligometastatic lesions, different ablation techniques may be evaluated according to the lesion’s location and surrounding structures as part of a local-control strategy.
Microwave · Cryoablation · IRE / NanoKnife*Y-90 Radioembolization
Y-90–loaded microspheres are delivered through an interventional approach into the blood supply of the target tumor, providing selective internal radiation within the lesion. This pathway combines imaging assessment, vascular intervention and nuclear medicine treatment.
Imaging + Interventional + Nuclear Medicine